Keynote: The Humble CEO, What Makes a Winning Mindset Emma Thorp•Peter Dines•Anne Horgan•Kath Mackay•Stuart Rose
Emma Thorp
Founder & Coach of Thorp Coaching
Peter Dines
Managing Director of Mercia Ventures
Anne Horgan
Partner at Cambridge Innovation Capital Limited
Kath Mackay
Director of Life Sciences at Bruntwood SciTech
Stuart Rose
CEO of OBN
Keynote: A Guide to Valuation for Fundraising Patrik Frei
Patrik Frei
CEO of Venture Valuation
Networking Lunch
Big Pharma Showcase Lilian Alcaraz•Mark Dowling•Laura Lane•Sarah Pollitt•Chloé Leprêtre
Lilian Alcaraz
VP, Early Innovation Partnering EMEA at Johnson Johnson Innovation
Mark Dowling
Head of Search & Evaluation for Immunology Business Development at Sanofi
Laura Lane
VP Ventures (Europe Head) at Eli Lilly and Company (Lilly Ventures)
Sarah Pollitt
Chair at ENSILITECH (part of Science Creates)
Chloé Leprêtre
Head of Global R&D Search and Evaluation at Servier
Panel: An Insight into how the IRA & BioSecure Act in the US, Impact External Markets Catherine Bacon•James Fry•Michael Malecki•Mel Walker•Emma Tinsley
Catherine Bacon
CEO of FingerPost
James Fry
Partner - Head of Life Sciences at Mills and Reeve LLP
Michael Malecki
President & CEO of Apex Market Access
Mel Walker
Managing Director of BioPharma Futures
Emma Tinsley
CEO of Weatherden
Panel: Working with a CRO to Minimise Risk & Maximise Success Zoë Johnson•Olivier Jarry•Craig Woods•Urmi Richardson•Bharat Chudasama
Zoë Johnson
CSDO at Molecule to Medicine
Olivier Jarry
Managing Director of Atlas Advisors
Craig Woods
CEO of Forge Genetics Ltd
Urmi Richardson
President EMEA at Thermo Fisher Scientific
Bharat Chudasama
Vice President, Head of Strategic Partnerships at Syneos Health
Keynote: London’s equity capital markets – where we are today Tim Davis
Tim Davis
Regional Head, UK Primary Markets at London Stock Exchange Group
Keynote: Role of the British Business Bank in UK Life Sciences Mark Andrews•Carmine Circelli
Mark Andrews
Investment Director, Funds of British Business Bank
Carmine Circelli
Director - Direct (Life Sciences) of British Business Bank
Panel: An Insiders Guide to Mergers & Acquisitions KIRAN GULATI•Alex Mackay•Damian Marron•Lynne Murray•William Hicks
KIRAN GULATI
Director, Business Operations of New England Biolabs (UK)
Alex Mackay
Partner at BDO LLP
Damian Marron
Head of Biopharma at Treehill Partners
Lynne Murray
Venture Partner at SR One Capital Management
William Hicks
Co-Chair, Life Sciences Practice at Mintz
Networking Lunch
Panel: A Review of the Latest Regulatory Updates Impacting R&D SME's
Panel: Building an inclusive & collaborative culture to thrive in times of change Andrew Davies•Rebecca Godfrey•Daniel Harrison•Zsolt Szelecki•Ewa Truchanowicz
Andrew Davies
Director Leasing of ARC Group
Rebecca Godfrey
COO at ExpressionEdits
Daniel Harrison
AIML Lead|Retail/CPG & Ireland at AWS
Zsolt Szelecki
Head of People Advisory Services at BDO
Ewa Truchanowicz
Advisor, Health Tech Exec, NED, Founder, Investor, Mentor of Bidshaper
CEO Spotlight Session Jenny Button•Jonathan Kwok•Adam Workman•James Field•Carina Kern
Jenny Button
Founder and CEO of Emm
Jonathan Kwok
CEO & co-founder of Infinitopes
Adam Workman
Head of Investments and New Ventures at Oxford University Innovation (OUI)
James Field
CEO of LabGenius
Carina Kern
CEO of LinkGevity
Science Spotlight One • Neuroscience, Sponsored by Syneos Zoë Johnson•Francesca Cordeiro•Andrew Mullen•Joanna Wolak•Kelvin Stott
Zoë Johnson
CSDO at Molecule to Medicine
Francesca Cordeiro
Founder & CEO of Novai
Andrew Mullen
CEO of Charco Neurotech
Joanna Wolak
President, CSO & Co-Founder of EndLyz Therapeutics
Kelvin Stott
CEO of Amporin Pharmaceuticals AG
Science Spotlight Three • Cell & Gene Therapy, Sponsored by ARC Simon Bornschein•Andrew Davies•Giles Dudley•Rafael E. Carazo Salas•David Hipkiss•Marina Tarunina•Tom Payne
Vice President, Liver Portfolio Development Lead at Ipsen
Josep Prous
CoFounder & CSO of CONNECTA Therapeutics
Jonathan Rees
Co-founder & CEO of MitoRx Therapeutics
Jeremy Skillington
CEO of Poolbeg Pharma plc
Mihriban Tuna
CEO of Immutrin
Julian Gough
CEO of Outsee
Science Spotlight Ten • AI for Drug Discovery & Development John Baker•Graham Ball•Kinga Bercsenyi•James Field•Jacob Hurst•Jordan Lane•Umang Patel•Philip Simister
John Baker
CEO of IMU Biosciences
Graham Ball
Director and CSO of Intelligent OMICS
Kinga Bercsenyi
Chief Business Officer at Arctoris
James Field
CEO of LabGenius
Jacob Hurst
Co-Founder & Chief Technology Officer of Etcembly
Jordan Lane
CSO at Ignota Labs
Umang Patel
CCIO at Microsoft
Philip Simister
Head of Science and Entrepreneur Advocate at OBN
Networking Lunch
Science Spotlight Eleven • AMR James Clark•Neciah Dorh•Stuart Hannah•Rachael McInnes•Kristof Van Emelen•Joanna Bacon
James Clark
CEO of Glox Therapeutics
Neciah Dorh
CEO of FluoretiQ
Stuart Hannah
CEO of Microplate Dx
Rachael McInnes
Chief Scientific Officer at Onya Therapeutics
Kristof Van Emelen
CEO of Obulytix
Joanna Bacon
Principal Investigator at UK Health Security Agency
Science Spotlight Thirteen • New Platforms & Technologies for Drug Discovery Valeria Chichagova•Jason Crain•Kenneth Harlow•Krzysztof Potempa•Zalán Péterfi•Sujit Tangadpalliwar•Juan Ignacio Imbaud
Valeria Chichagova
Director of Technology at Newcells
Jason Crain
Senior Research Scientist & Visiting Professor at IBM Research Europe / University of Oxford
Kenneth Harlow
CEO of Aligned Bio AB
Krzysztof Potempa
Founder and CEO of BRAINCURES
Zalán Péterfi
CEO of VRG Therapeutics
Sujit Tangadpalliwar
Founder & CEO of Biolligence
Juan Ignacio Imbaud
CEO of PROTEIN ALTERNATIVES
Science Spotlight Two • Medtech & Digital Health, Sponsor EY Laszlo Bax•Nicholaas Fosselle•Jiva Muthu•Reshania Naidoo•Karin Schmitt•Jasper Van Hoorick•James Jackson
Laszlo Bax
CEO & Co-Founder of Braingaze
Nicholaas Fosselle
CEO of RheumaFinder
Jiva Muthu
CEO of Exsurgo
Reshania Naidoo
Manager at EY
Karin Schmitt
Chief Operating Officer at Mursla Bio
Jasper Van Hoorick
CEO of BIO INX BV
James Jackson
CEO of Digostics
Science Spotlight Four • Vaccine Technology Jonathan Heeney•Neil Murray•Hanne Noyen•Nam Chol Park•Jeremy Salt•Yvanne Enever
Jonathan Heeney
Founder & Chief Executive Officer of DIOSynVax
Neil Murray
CEO of ReNewVax
Hanne Noyen
Corporate Development Manager at Ziphius
Nam Chol Park
Chief Business Officer at Oxford Vacmedix UK Ltd
Jeremy Salt
CEO of The Vaccine Group
Yvanne Enever
CEO of PHARMExcel
Networking Lunch
Spotlight: Life Science Accelerator @ Alderley Park Andy Roberts•Jessica McCreadie•Andy Round•Uday Phadke•Jacob Thompson•Yogesh Prasad•Dave Cook•Liza Levy•Chris Bullock•Gray Kueberuwa
Innovate UK Cancer Vaccines Showcase Kristen Albright•Lennard Lee•Sarah Maguire•Kerstin Papenfuss•Karen Spink•Aleck Jones
‘Therapeutic cancer vaccines are receiving a significant amount of attention globally as the next wave of personalised treatments. In this session we will learn how the UK is in a unique position to deliver these innovative medicines to cancer patients. We will be showcasing some potentially transformative cancer therapeutic innovations that have been supported and funded by Innovate UK. This includes the launch of an exciting new venture with an approach aimed at sparking the development of a curative therapy for children with cancer.’
Kristen Albright
CEO of Prokarium
Lennard Lee
Medical Director of Ellison Institute of Technology, Oxford Limited
Sarah Maguire
CSO at AilseBio
Kerstin Papenfuss
Director Pharma of Deep Science Ventures
Karen Spink
Head of Medicines at Innovate UK (UKRI)
Aleck Jones
Co-Founder of Kindling Bio
Science Spotlight Six • Women's Health Samantha Betz•Melis Eda Ekinci•ANGELA HOBBS•Emma Hayhurst•Chris Phillips•Elien VAN HECKE
Samantha Betz
Finance Director of Zedsen
Melis Eda Ekinci
Founder & CEO of Woost
ANGELA HOBBS
CEO of Wilkinson Hall
Emma Hayhurst
CEO of Llusern Scientific Limited
Chris Phillips
Founder/CSO of Digistain
Elien VAN HECKE
CCO at FERTIGA
Science Spotlight Nine • Ageing, Microbiome and Injury Suzanne Eldridge•Carina Kern•Nik Sharma•Janette Thomas•David Weinkove•Simon Ruck
VP, Therapeutic Strategy & Innovation at Syneos Health
Francesco Sergi-Lindell
CEO of PreTT ApS
Ninna Struck Rossen
CEO of Metsystem
Nigel Trim
CEO of SonoTarg
Carles Domenech
Executive Chairman and CEO of Ability Pharmaceuticals
Science Spotlight Fourteen • Synthetic Biology Pedro Correa de Sampaio•Gustaf Hemberg•Richard Kitney•Zehra Nizami•Cai Linton
Pedro Correa de Sampaio
CEO of Neobe
Gustaf Hemberg
Founder & CEO of Scindo
Richard Kitney
Professor and Co-Director of SynbiCITE
Zehra Nizami
Principal Scientist at PartitionBio Ltd
Cai Linton
CEO of Multus Biotechnology
Academic Poster Presentations
Academic Poster Presentations
BDO ‘R&D Tax & Financial Strategy’
Delegates are invited to join the BDO team for a ‘drop-in’ session on Tuesday 1 April from 12.00 – 14.00 at BioTrinity 2025. The session is aimed at those running R&D SMEs, and at varying stages of the pharma life cycle. It will provide a quiet space for one-to-one conversations with financial experts & strategic consultants on matters ranging from: financial strategy, audit & assurance, R&D tax, funding, deals, and outsourcing of business services.
Breakfast with Syneos
The BioTrinity programme is designed to be relevant, useful & thought-provoking and features three tracks over two-days, which includes:
Two Scientific Spotlight tracks, featuring update keynotes and showcase presentations from some of the most exciting R&D companies at series A stage across a range of therapy areas
A Business & Investment focused track, featuring keynotes and discussions addressing a broad range of hot topics currently impacting life sciences
CALL FOR SPEAKERS!
Email Jane O'Driscoll if you'd like to be considered for a speaking or presentation opportunity across any of the science or business sessions.
Click herefor a downloadable version of the BioTrinity programme
